MD

$19.62

Post-MarketAs of Mar 17, 8:00 PM UTC

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Recent News

Zacks
Mar 16, 2026

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Here's Why Investors Continue to Hold Pediatrix Medical Stock

Favorable payer mix, higher neonatology acuity and prudent acquisitions will support MD's growth, while shares look undervalued versus industry peers.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

1 Unpopular Stock That Should Get More Attention and 2 We Question

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 2, 2026

Pediatrix Buybacks And Return To Profitability Recast Shareholder Prospects

Pediatrix Medical Group (NYSE:MD) reported its full year and fourth quarter earnings alongside confirmation of substantial share repurchases. The company completed significant buybacks across multiple authorized programs, including activity tied to a 2025-announced repurchase plan. Management also reported a transition to profitability for the full year, marking a key update in the company’s recent financial profile. Pediatrix focuses on physician services for newborn, maternal fetal and...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 2, 2026

Is Pediatrix Medical Group (MD) Pricing Reflect Its DCF And P/E Valuation Gap

If you are trying to figure out whether Pediatrix Medical Group is genuinely good value or just looks cheap on the surface, this breakdown is for you. The share price recently closed at US$19.85, with returns of 0.6% over 7 days, a 7.2% decline over 30 days, a 6.8% decline year to date, a 36.8% gain over 1 year and 31.5% over 3 years, while sitting 28.3% lower over 5 years. Recent coverage has focused on Pediatrix Medical Group's position in the US healthcare space and how investors are...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.